TABLE 3.
Outcome and survival of fusariosis patients treated with voriconazole, by underlying condition
| Underlying condition (no. of patients) | Median (range) duration of voriconazole therapy (days) | No. (%) with clinical response | Median (range) survival (days) | No. that died (no. that died due to IFI) |
|---|---|---|---|---|
| HSCT (13) | 18 (3-182) | 5 (38) | 27 (6-202) | 9 (4) |
| HMa (44) | 61 (1-480) | 20 (45) | 112 (4-808) | 27 (15) |
| Chronicb (9) | 57 (3-267) | 4 (44) | 200 (6-435) | 5 (3) |
| Otherc (7) | 30 (19-259) | 5 (71) | Not reached (19-365) | 2 (0) |
| Total (73) | 57 (1-480) | 34 (47) | 120 (4-808) | 43 (22) |
a
HM, hematologic malignancy.
b
Chronic conditions included lymphoma (3 patients), aplastic anemia (3), tumor lysis syndrome (1), neuroblastoma (1), and kidney transplant (1).
c
Other conditions were immunocompetence (4 patients), diabetes mellitus (2), paralytic ileus (1), and burns (1).